EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

A Visual Analysis of the Research Dynamics in Resistance to EGFR Inhibitors for NSCLC

Jun Shao, Yunru Gu, Renhua Guo iD, Jiali Xu

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s465238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Jun Shao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm, ErbB Receptors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsCarcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmErbB ReceptorsLung NeoplasmsProtein Kinase InhibitorsHumansBibliometricsMutation

Stichwörter der Autor:innen

EGFR mutationEGFR-TKIsNSCLCbibliometric analysishot SPOTS

Substanzen

Antineoplastic AgentsEGFR protein, humanErbB ReceptorsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.

ORCID-Profile: Renhua Guo

Zitieren

APA

Shao, J., Gu, Y., Guo, R., & Xu, J. (2024). A Visual Analysis of the Research Dynamics in Resistance to EGFR Inhibitors for NSCLC. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s465238

Vancouver

Shao J, Gu Y, Guo R, Xu J. A Visual Analysis of the Research Dynamics in Resistance to EGFR Inhibitors for NSCLC. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s465238

BibTeX
@article{Shao2024,
  author = {Shao, Jun and Gu, Yunru and Guo, Renhua and Xu, Jiali},
  title = {A Visual Analysis of the Research Dynamics in Resistance to EGFR Inhibitors for NSCLC},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s465238}
}
Kostenlos starten →